Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

BeOne Medicines (BEIGF) Prepaid Assets (2016 - 2025)

BeOne Medicines (BEIGF) has disclosed Prepaid Assets for 11 consecutive years, with $212.8 million as the latest value for Q4 2025.

  • Quarterly Prepaid Assets rose 10.28% to $212.8 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $212.8 million through Dec 2025, up 10.28% year-over-year, with the annual reading at $212.8 million for FY2025, 10.28% up from the prior year.
  • Prepaid Assets for Q4 2025 was $212.8 million at BeOne Medicines, down from $232.6 million in the prior quarter.
  • The five-year high for Prepaid Assets was $1.4 billion in Q4 2022, with the low at $168.2 million in Q1 2025.
  • Average Prepaid Assets over 5 years is $287.5 million, with a median of $233.8 million recorded in 2021.
  • The sharpest move saw Prepaid Assets soared 401.27% in 2022, then tumbled 80.99% in 2023.
  • Over 5 years, Prepaid Assets stood at $270.2 million in 2021, then skyrocketed by 401.27% to $1.4 billion in 2022, then crashed by 80.99% to $257.5 million in 2023, then dropped by 25.07% to $192.9 million in 2024, then grew by 10.28% to $212.8 million in 2025.
  • According to Business Quant data, Prepaid Assets over the past three periods came in at $212.8 million, $232.6 million, and $280.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.